Krystal Biotech, Inc.KRYSNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P95
Near historical high
vs 2Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 95.44% |
| Q3 2025 | -24.79% |
| Q2 2025 | 70.26% |
| Q1 2025 | -41.39% |
| Q4 2024 | -10.22% |
| Q3 2024 | 1512.12% |
| Q2 2024 | -126.23% |
| Q1 2024 | 319.69% |
| Q4 2023 | 65.93% |
| Q3 2023 | 37.92% |
| Q2 2023 | -30.72% |
| Q1 2023 | -17.14% |
| Q4 2022 | -13.41% |
| Q3 2022 | 54.28% |
| Q2 2022 | -177.93% |
| Q1 2022 | 25.87% |
| Q4 2021 | -188.08% |
| Q3 2021 | 28.37% |
| Q2 2021 | -4.92% |
| Q1 2021 | -20.31% |
| Q4 2020 | -18.59% |
| Q3 2020 | -33.56% |
| Q2 2020 | 18.64% |
| Q1 2020 | 11.62% |
| Q4 2019 | -66.06% |
| Q3 2019 | -0.81% |
| Q2 2019 | -30.92% |
| Q1 2019 | 8.61% |
| Q4 2018 | -81.34% |
| Q3 2018 | -19.90% |
| Q2 2018 | 31.70% |
| Q1 2018 | -11.38% |
| Q4 2017 | -93.72% |
| Q3 2017 | -169.12% |
| Q2 2017 | -58.75% |
| Q1 2017 | 70.15% |
| Q4 2016 | -176.85% |
| Q3 2016 | 0.00% |